1. 909PPlasma miR-371a-3p for detection of non-teratomatous viable germ cell tumor in testicular cancer. (23rd October 2018) Authors: Nappi, L; Thi, M; Eigl, B J; Lum, A; Huntsman, D; Martin, C; Neil, B O; Khalaf, D J; Chi, K N; Gleave, M E; So, A; Black, P; Daneshmand, S; Nichols, C R; Kollmannsberger, C K Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 934PCirculating tumour DNA (ctDNA) utility as a biomarker for metastatic urothelial carcinoma (mUC). (1st October 2019) Authors: Lavoie, J-M; Vandekerkhove, G; Annala, M; Taavitsainen, S; Sundahl, N L; Walz, S; Sano, T; Khalaf, D; Todenhöfer, T; Ost, P; Kollmannsberger, C K; Chi, K N; Black, P C; Wyatt, A W; Eigl, B J Journal: Annals of oncology Issue: Volume 30(2019)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 983PDifferential expression of circulating miR375 and miR371 to detect teratoma and viable germ cell malignancy. (1st October 2019) Authors: Nappi, L; Thi, M; Eigl, B J; Chi, K N; Gleave, M E; So, A; Black, P C; Hamilton, R; Daneshmand, S; Nichols, C R; Kollmannsberger, C K Journal: Annals of oncology Issue: Volume 30(2019)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗